文献速递间质性肺疾病

肺道引作为特发性肺纤维化患者的中医康复方案:一项随机对照试验

Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF: A randomized controlled trial.
PubMed 文献 · Respirology · 2020-11-08

主要终点为6分钟步行距离(6MWD)和SGRQ-I生活质量评分。结果显示PD组6MWD在2个月和6个月时均显著优于对照组,差异超过MCID,且安全性良好;但SGRQ-I、mMRC、FVC和DLCO无显著变化。

要点

  • 肺道引可显著提高IPF患者6分钟步行距离,2个月时较对照增加48.02米。
  • 肺道引组6MWD改善在6个月时仍优于对照,差异为50.93米。
  • 肺道引对生活质量、呼吸困难、肺功能指标无显著影响。

核心结论

  • 为期2个月的肺道引康复干预可显著改善IPF患者的运动耐力,且效果在干预后4个月仍部分维持。
  • 肺道引安全有效,可作为肺康复的替代方案用于提高IPF患者运动耐量。

研究设计与样本

  • 患者随机分为三组:肺道引组(每日2次,每周5天,共2个月)、运动组(功率自行车,每日30分钟,每周5天,共2个月)和对照组(维持日常活动)。
  • 主要结局为基线至1个月、2个月(干预结束时)和6个月(干预后4个月)的6MWD和SGRQ-I评分变化。
  • 次要结局包括FVC、DLCO(%预计值)和mMRC变化。

主要发现

  • 2个月康复后,6MWD在肺道引组增加60.44米,运动组增加32.16米,对照组增加12.42米。
  • 2个月时,肺道引组与运动组6MWD变化差异为28.78米(95%CI:0.54至56.01;P=0.044),与对照组差异为48.02米(95%CI:23.04至73.00;P<0.001)。
  • 6个月时,肺道引组与运动组6MWD变化差异为25.61米(95%CI:-0.67至51.89;P=0.058),与对照组差异为50.93米(95%CI:25.47至76.40;P<0.001)。
  • 肺道引组和运动组的SGRQ-I评分、mMRC呼吸困难评分、FVC和DLCO(%预计值)均无显著变化。

临床怎么用

  • 对于IPF患者,可考虑将肺道引作为肺康复方案以改善运动耐力,尤其适用于无法进行常规运动康复者。
  • 实施肺道引时需注意其为期2个月、每日2次、每周5天的干预频率,并关注6MWD的改善效果。
  • 肺道引对生活质量和肺功能无明显改善,临床决策时应结合患者具体康复目标。

局限性

  • 干预时间较短(2个月),长期效果及依从性未充分评估。
  • 原文未报告盲法、分配隐藏等偏倚控制细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: IPF is a chronic progressive lung disease in which PR provides benefit for patients. PD, a TCM PR programme, has known effectiveness in COPD, but its utility in IPF is unknown. We investigated its effectiveness and safety in patients with IPF. METHODS: A 6-month randomized controlled trial (RCT) was conducted in three Chinese clinics. Ninety-six participants diagnosed with IPF were randomly assigned to one of the three groups: the PD group received a PD programme two times a day, 5 days/week for 2 months, and the exercise group exercised via a stationary cycle ergometer, 30 min/day, 5 days/week for 2 months. Volunteers in the control group were advised to maintain their usual activities. Primary outcomes were changes from baseline in the 6MWD and HRQoL score on the SGRQ-I at 1 and 2 months (at the end of the intervention) and at 6 months (4 months after the intervention). Secondary outcomes measures included FVC, DLCO (% predicted) and the changes in mMRC. RESULTS: The 6MWD was increased in the PD group compared to exercise and control groups. 6MWD increased by 60.44 m in the PD group, 32.16 m in the exercise group and 12.42 m in controls after the 2 months of rehabilitation programme. The between-group differences in the change from baseline were 28.78 m (95% CI: 0.54 to 56.01; P = 0.044) and 48.02 m (95% CI: 23.04 to 73.00; P < 0.001) at 2 months, and 25.61 m (95% CI: -0.67 to 51.89; P = 0.058) and 50.93 m (95% CI: 25.47 to 76.40; P < 0.001) at 6 months, respectively, including a difference exceeding the MCID. There was no significant change in the SGRQ-I score, the mMRC dyspnoea score, FVC and DLCO (% predicted) in either the PD or exercise groups. CONCLUSION: Two months after the intervention, a clinically meaningful difference in 6MWD was observed favouring the PD programme. The PD programme is safe and effective as a rehabilitation intervention designed to increase exercise tolerance and is an appropriate substitute for PR.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Zhou M, Zhang H, Li F, et al. Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF: A randomized controlled trial. Respirology. 2020. PMID: 33164264. doi:10.1111/resp.13972

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。